Retreatment with aromatase inhibitor therapy in the management of granulosa cell tumor

• Over 90% of granulosa cell tumors have a FOXL2 mutation that contributes to aromatase upregulation. • Chemotherapy has demonstrated limited efficacy in the treatment of granulosa cell tumors. • A patient with recurrent granulosa cell tumor responded briefly to anastrazole treatment. • Retreatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Melissa, Huang, Gloria S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750011/
https://www.ncbi.nlm.nih.gov/pubmed/26937482
http://dx.doi.org/10.1016/j.gore.2015.12.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750011/
https://www.ncbi.nlm.nih.gov/pubmed/26937482
http://dx.doi.org/10.1016/j.gore.2015.12.004

Ejemplares similares